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A B S T R A C T
Background: Little is known about the burden and patterns of maternal morbidity during childbirth,
particularly in the Middle East Region. Investigating the patterns of maternal morbidity can be useful in
guiding improvement in the quality of maternal services, and informing policy debates on women’s health.
Objective: To examine the incidence, types and patterns of management of severe and non-severe
maternal morbidities of Palestinian women during pregnancy, labour, delivery and up to seven days
postpartum in one Palestinian hospital.
Methods: A prospective hospital-based study was conducted for a 3-month period in 2011–2012,
reviewing hospital records for all pregnant women (1.583) admitted to the governmental hospital in
Ramallah, Palestine.
Findings: Of all pregnant women included in this analysis (1.558), 419 (26.9%) women experienced one
or more maternal morbidities and 15 (0.96%) women survived a life-threatening complication (near
miss). Of all women who suffered morbidities, 69 (16.5%) had vaginal deliveries, 61 (14.6%) had cesarean
sections, 179 (42.7%) had abortions/miscarriage, and 110 (26.3%) experienced complications during
pregnancy or the post-partum. Hemorrhage during pregnancy, birth or postpartum was the most
common morbidity. Of those who gave birth, women who gave birth by cesarean sections were three
times more likely to suffer from morbidities than those who had vaginal delivery.
Conclusions: The burden of maternal morbidity for Palestinian women between the ages of 16 and 48 is
high. In Palestine, maternal morbidity can be prevented by promoting a rational use of cesarean section,
avoiding unnecessary medicalization, reducing unwanted pregnancies and updating practices of
providers related to abortion/miscarriage care.
 2015 Australian College of Midwives. Published by Elsevier Australia (a division of Reed International
Books Australia Pty Ltd). All rights reserved.
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While maternal health is considered a priority in the Middle
East Region, little is known about the burden and patterns of
maternal morbidity that are an integral part of women’s lives.1 In
Palestine, as in many other countries in the region, the coverage
of antenatal care and childbirth in hospitals is almost universal
and service utilization is high. Midwives attend the majority of* Corresponding author at: Institute of Community and Public Health, Birzeit
University, Box 14, Birzeit, West Bank, State of Palestine. Tel.: +972 2298 2020; fax:
+972 2298 2079.
E-mail addresses: saharjhassan@gmail.com (S.J. Hassan), lwick@birzeit.edu
(L. Wick), jd16@aub.edu.lb (J. DeJong).
http://dx.doi.org/10.1016/j.wombi.2015.08.008
1871-5192/ 2015 Australian College of Midwives. Published by Elsevier Australia (a vaginal births. However, practices during childbirth are not
consistent with current evidence.2 These practices include routine
amniotomy, augmentation of labour, episiotomy, and intravenous
ﬂuids, frequent vaginal examination and restrictions on mobility,
and on drinking liquids. Maternal morbidity data can provide
indicators of the burden and management of disease. Improving
quality of care has been shown to be a complex process in all
environments, but in contexts with on-going political and
economic instability, barriers to building a healthcare system
and strengthening institutions is even more daunting.
Currently, the only two national indicators collected in
Palestine on hospital-based deliveries are cesarean section (CS)
(with no indications) (20.3%) and maternal deaths (24.1 per
10,000). Maternal mortality is a rare incident and is likely to be
underreported even in developed countries3 and country-speciﬁcdivision of Reed International Books Australia Pty Ltd). All rights reserved.
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costly to obtain. Currently, only 57% of married women aged 15–49
years use family planning methods, and the intrauterine device is
the most common method (26%).4
Research on maternal morbidity has suffered from the use of
different deﬁnitions and criteria (disease-speciﬁc, management,
or organ system dysfunction).5 A recent WHO scoping exercise
emphasized the need for including non-life threatening maternal
morbidities in assessments,6 in addition to near-miss cases,
deﬁned as ‘‘a woman who nearly died but survived a complication
that occurred during pregnancy, childbirth or within 42 days of
termination of pregnancy’’.7 In the past decade, studies by the
Choices and Challenges in Changing Childbirth research network
in four Arab countries were focused on normal childbirth and
showed that, births occur primarily in hospitals, with skilled birth
attendants, yet practices during normal labour are not according
to the best available evidence.2,8 These studies documented
overuse of unnecessary interventions during normal labour,
escalation in the CS rate9,10 and challenges in the existing health
systems.11 On the other hand, little is known about the magnitude
of maternal morbidities.12 A recent cross-sectional study in
Marrakech showed that 44% of postpartum women reported at
least one morbid event, including vaginal discharge, hemorrhoids,
breast, episiotomy and anal problems, prolapse, bleeding, urinary
problems and others.12 A study in Qatar found that housewives
and pregnant women with low monthly household income
suffered higher risk of complications during pregnancy, primarily
from gestational diabetes, hypertension, hemorrhage and ane-
mia.13 A prospective study from six public hospitals in Iraq
studied the quality of care provided for women with severe
complications reported suboptimal use of magnesium sulfate for
preeclampsia and oxytocin for prevention of postpartum hem-
orrhage (PPH).14
With the aim of improving maternal and neonatal health care in
a major public referral hospital in the West Bank of Palestine, the
authors participated in a WHO funded four hospital comparative
study of maternal and neonatal near-miss cases in Lebanon, Syria,
Egypt and Palestine. This article presents the medical record
review data analysis from the formative phase of this study in
Ramallah Hospital, Palestine. In order to provide a broad snapshot
of maternal morbidity, we decided to select not only the near-miss
cases when women survive life-threatening conditions (i.e. organ
dysfunction), but to include additionally less severe morbidities
which may affect the quality of life of the woman and the family for
years to come.15 This information should be useful in understand-
ing Palestinian women’s needs during the reproductive years,
guiding improvement in the quality of maternal services, and
informing clinical and policy debates on women’s health in the
country. This facility-based data, which was rigorously and
systematically collected and analyzed, can provide indications
for urgently needed interventions in women’s health. Stimulating
debate is important not only for women’s physical and psycholog-
ical well-being, but also for the survival and development of the
child and entire family,15 in a context lacking social services, where
women assume the role of caretakers of family members of all ages
and disabilities.16
The aim of this study is to examine the incidence, types and
patterns of management of severe and non-severe maternal
morbidities of Palestinian women during pregnancy, labour,
delivery and seven days postpartum in one major Palestinian
referral government hospital in the West Bank.
2. Methods
This prospective study conducted in the public hospital in
Ramallah, Palestine between September 25, 2011 and January 6,2012 was based on medical records review of all admissions to the
maternity ward. The data was collected as part of a multi-country
study of maternal and neonatal near-miss women in four
hospitals (Lebanon, Syria, Egypt and Palestine) using the WHO
standard form (Individual Form HRP A65661).17 Since it was
difﬁcult to identify women who experience a near-miss event
among admissions to the hospital (eligibility criteria for the
WHO standard form), we chose to ﬁll the form for all pregnant
women admitted to give birth, to be observed or treated for
pregnancy complications or complaining of signs of abortion/
miscarriage or ectopic pregnancy as well as postpartum women
with complications (the ﬁrst seven days after giving birth),
and maternal deaths. The maternal outcome, gestational age and
neonatal outcome were also collected during the hospital stay.
We also collected data on the coverage of selected evidence-
based interventions used for prevention and treatment of (PPH),
severe preeclampsia, eclampsia, use of antibiotics for prevention
of infection during CS and treatment of sepsis and preterm
labour.
2.1. Study setting
The study was conducted in Ramallah Hospital, a general referral
public hospital in Ramallah governorate that serves 75 localities and
6 refugee camps. In 2011, 4517 deliveries took place in the maternity
ward and the CS rate was 21.4%. The maternity ward consists of
28 beds and offers free services covered by the local health
insurance, including the neonatal intensive care unit. The hospital is
a main teaching hospital for Palestinian medical, nursing and
midwifery students.
2.2. Data collection
The data was collected by a midwife and a nurse trained by the
principal investigator (PI) on the data collection tool, data
extraction through record review and identiﬁcation of complica-
tions and near-miss cases (WHO deﬁnition). The data was
collected on a daily basis from the medical records that are not
yet computerized, for all eligible women admitted over 24 h,
regardless of gestational age, up to 7 days postpartum. The
hospital discharge register was used to identify all women as it
was the most accurate and complete register. We cross-checked
women who gave birth with the birth register every day. We
reviewed the medical records of all women for registration,
history, physicians’ orders, nurses’ notes, observation, surgery
notes, medication sheets and laboratory results. Women who
were identiﬁed as near-miss cases or with severe complications
were veriﬁed by a senior obstetrician.
2.3. Data analysis
The data was entered into CsPro software,18 which helped to
ensure high quality data entry and quality checks on data entry.
Data analysis was performed using IBM SPSS (version 19).
Descriptive statistics, frequency counts and percentages were
produced for all women and then stratiﬁed by parity and mode of
delivery. We created the maternal morbidity variable from the data
set and accounted for all women who suffered from any of the
following conditions: obstetric or maternal complications (direct
and indirect causes), related procedures/interventions, and life-
threatening complications. Descriptive analysis was also per-
formed for perinatal outcomes of pregnancy and stratiﬁed by
morbidity. Independent t-test was used to test the difference
between means, and Chi-square and Fisher’s exact statistics were
used to compare proportions. P-values of less than 0.05 were
considered signiﬁcant.
Table 1
Deﬁnition of direct and indirect causes of maternal morbidity and maternal near-miss.20,49
Direct causes of maternal morbidity -Hemorrhage: hemorrhage occurred during pregnancy, labour, delivery or postpartum including postpartum
hemorrhage and other obstetric hemorrhage related to abortion, ectopic pregnancy, placenta previa, accreta/increta/
percreta placenta, abruptio placenta, ruptures uterus
-Infection: abortion related infection, puerperal endometritis, pyelonephritis, other systemic infections/sepsis
-Preeclampsia/eclampsia.
Indirect causes of maternal morbidity -Chronic hypertension deﬁned as blood pressure >140/90 mmHg before 20 weeks of gestation
-Other conditions such as HIV/AIDS, inﬂuenza-like illness, anemia (deﬁned as hemoglobin <7%, g), malaria, embolic
disease, cancer, heart, lung, renal or hepatic disease
-Coincidental condition such as violence, accidents, poisoning, and self harm
Maternal near miss All women that survived a severe life threatening complication during pregnancy, childbirth, or within seven days of
termination of pregnancy such as: organic dysfunction of the cardiovascular, respiratory, renal, coagulation, hepatic,
neurologic or uterine body systems
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Our operational deﬁnition of maternal morbidity included all
women who suffered any of the following conditions: complica-
tions classiﬁed into direct and indirect causes, life-threatening
complications (near miss event) during pregnancy, childbirth, or
within seven days of termination of pregnancy, and intervention/
procedure-related morbidity (if the woman received any inter-
ventions during the hospital stay for the followings conditions:
manual removal of retained products or placenta, or blood
products given without being documented as a complicated or a
near miss condition.)19 Preterm birth was deﬁned as any birth that
occurred before 37 weeks of gestation.
We deﬁned direct causes of complications as conditions related
directly to pregnancy or childbirth, listed in the WHO data
collection form. Indirect causes relating to pre-existing or newly
developed disease during pregnancy were also retrieved from the
WHO data collection form (Table 1). We deﬁned maternal near-
miss according to the WHO deﬁnition.20
2.5. Ethical approval
The study protocol was approved by the WHO Research Ethics
Review Committee, the Institutional Review Board at the American
University of Beirut and the Institute of Community and Public
Health Ethical Review Committee of Birzeit University in 2011. The
research team participated in an online course on ethics by theAll El igible wom en
n= 1,583 
Eli gible women fo r
analysis = 1,558 






morbidity  = 61 
Vagin al deliver y 
morbidi ty = 69 
Fig. 1. Distribution of women anNational Institute of Health ofﬁce of Extramural Research. All data
collected was secured in the PI ofﬁce and all computers used for
data entry and analysis were secured by passwords.
3. Results
3.1. Women’s characteristics
Among the 1583 eligible women, data on a total of
1558 women were included in the analysis after excluding
multiple births (Fig. 1). A total of 1209 (77.6%) women gave
birth, and 349 (22.4%) women were classiﬁed as cases of
abortion/miscarriage or complication during pregnancy or
postpartum. About one third of the primiparae women were
young (below age of 20) and 153 (16%) of multiparae women
were above 35 years old (Table 2). The proportion of primiparae
women whose deliveries were induced was twice that of multiparae
women. With the exception of two women, all women admitted
with ‘‘no labour’’ gave birth by cesarean section. In addition, the
cesarean section rate was higher in the primiparae women
compared to multiparae women (Table 2).
There were 196 (12.6%) women admitted as abortion/miscar-
riage cases. Among those, 144 (73.6%) women were multiparae and
52 (26.4%) were primiparae. The mean age of these women was
28.7 years and the mean gestational age on admission was
10.7 weeks. The majority of these women 179 (91.3%) received
medical methods for uterine evacuation (primarily medications 
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N (%) N (%)
Age in years (mean, SD) (23.4, 5.05) (28.7, 5.4) <0.0001
16–20 82 (32.4) 28 (2.9)
21–34 158 (62.5) 771 (80.6)
35–48 13 (5.1) 153 (16.0)
Gestational age in
weeks (mean, SD)
(38.4, 2.9) (38.7, 2.1) 0.092
25–36 weeks 28 (11.1) 98 (10.3)
37–42 weeks 223 (88.5) 858 (89.8)
Onset of labour
Spontaneous 179 (70.8) 756 (80.9) 0.19
Induced 48 (19.0) 83 (8.7)
No labour 26 (10.3) 117 (12.2)
Mode of delivery 0.680
Vaginal delivery 189 (74.7) 727 (76.0)
Cesarean section 64 (25.3) 229 (24.0)
Fetal presentation at delivery 0.384
Cephalic 240 (94.9) 918 (96.0)
Breech 11 (4.3) 28 (2.9)
Other 2 (0.8) 10 (1.0)
No previous CS delivery 253 (100) 746 (78)
1 Previous one CS delivery 0 135 (14.1)
2 or more previous
CS deliveries
0 75 (7.8)
S.J. Hassan et al. / Women and Birth 28 (2015) e148–e156 e151like synthetic prostaglandin analog, such as misoprostol) or
curettage (Fig. 2).
Pregnant women not in labour but who experienced complica-
tions accounted for 153 (10%) women from our sample with a
mean age of 26.8 years. Among these women with complications,
49 (32%) were primiparae. These women were admitted forAbortion s/
(N=
Primiparae  (N=52) 
26.5% 
Final mode of abortion/m iscarria ge 
-Medica l meth ods  for uterine  
evacuati on =  44 
-Abor tio n/miscarria ge not requir ing 
med ical or surgical procedu res  = 5 
-Curettage = 2 
-Laparatomy for Ectopic pregnancy = 1 
Co-morb idi ties  = 47 (90.4% ) 
Abortion/miscar riage  
before admission = 3 
Fig. 2. Characteristics of women admtreatment or observation of speciﬁc morbidities such as bleeding,
preeclampsia/eclampsia, infection or other medical conditions.
Among them, 110 (71.9%) suffered co-morbidities and one woman
was classiﬁed as near-miss cases according to WHO criteria
(Table 3).
3.2. Incidence and types of maternal co-morbidities
Out of the 1558 women, a total of 419 (26.9%) women
experienced one or more maternal co-morbidities and 15 women
survived a life threatening complication (near-miss) (Table 2). Of
all women, 343 (22%) suffered one type of morbidity, 64 (4.1%)
women suffered two to three morbidities, and 12 (0.8%) women
suffered four to 12 morbidities. Of those who experienced
morbidities, 69 (16.5%) women had vaginal delivery, 61 (14.6%)
had cesarean sections, 179 (42.7%) had abortions, and 110 (26.3%)
were pregnant or in their postpartum period (Fig. 1). Abortion/
miscarriage-related hemorrhage was the most common compli-
cation documented for women with morbidities (Fig. 2). The
curettage procedure was utilized for 22 women (Fig. 2).
Among the 1209 women who gave birth, 130 (31%) had
morbidities and 12 had near-miss events (Fig. 1). The women who
had cesarean sections were three times more likely to experience
morbidities than those who had vaginal delivery (20.8% vs 7.5%
respectively). The most frequent complications were hemorrhage,
pre-eclampsia/eclampsia, and indirect causes (Table 3).
More than a quarter 110 (26.3%) of the morbidities women
incurred were due to complications during pregnancy or postpar-
tum and the most common complications among these women
were hemorrhage (28.1%), infection (19.6%) and pre-eclampsia/
eclampsia (12.4%) (Table 3).
Approximately, a quarter of all women 387 (24.8%) suffered
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Table 3
Incidence of women who suffered maternal morbiditiesa during pregnancy and childbirth by mode of delivery in the study group.











Direct Postpartum hemorrhage 22 (2.4) 9 (3.1) 0 0 31 (2.1)
Other obstetric hemorrhage 20 (2.2) 17 (5.8) 176 (89.8) 43 (28.1) 256 (16.4)
Preeclampsia/Eclampsia 19 (2.1) 27 (9.2) 0 19 (12.4) 65 (4.2)
Infection 5 (0.5) 2 (0.7) 0 32 (19.6) 39 (2.5)
Indirect Other systems 4 (0.4) 14 (4.8) 2 (1) 15 (9.8) 35 (2.2)
Others Intervention related 24 (2.6) 18 (6.1) 10 (5.1) 7 (4.6) 59 (3.8)
Near miss Massive transfusion of blood
or red cells (5 units)
3 (0.3) 5 (1.7) 1 (0.5) 0 9 (0.6)
Hysterectomy 1 (0.1) 3 (1) 0 0 4 (0.3)
Other organic dysfunctions 1 (0.1) 1 (0.3) 1 (0.3) 1 (0.3) 4 (0.3)
ICU admission 2 (0.2) 6 (2.0) 1 (0.5) 0 9 (0.6)
Any morbidity (women) 69 (7.5) 61 (20.8) 179 (91.3%) 110 (71.9) 419 (26.9)
Maternal near-miss 4 (0.4) 8 (2.7%) 2 (1.0%) 1 (0.7%) 15 (1)
Other obstetric hemorrhage includes: Abortion related hemorrhage, ectopic pregnancy, placenta previa, accreta/increta/percreta placenta, abruptio placenta, ruptures uterus,
any other obstetric hemorrhage not including postpartum hemorrhage.
Infection includes: Abortion related infection, puerperal endometritis, pyelonephritis, inﬂuenza-like illness, other systemic infections/sepsis.
Other systems includes: chronic hypertension, HIV/AIDS, anemia, malaria, embolic disease (thrombo/emniotic/air embolism), cancer, heart disease, lung disease, renal disease,
hepatic disease, coincidental conditions (includes violence, accident, poisoning, self-harm).
Intervention related: include removal of retained products, manual removal of placenta, blood products (<5 units) and not documented as suffering a complication or near miss.
Any morbidity: Any woman who suffers at least one morbidity related to direct, indirect, near-miss condition, or received intervention to treat morbidity and not explicitly
documented as a complication or near miss.
Maternal near-miss: a woman who nearly died but survived a complication that occurred during pregnancy, childbirth or within 42 days of termination of pregnancy. Maternal
near-miss: according to the WHO criteria included: Other organic dysfunctions: Includes all conditions of organic dysfunction (cardiovascular, respiratory, renal, coagulation,
hepatic, neurologic) without hysterectomy and massive transfusion of blood or red cells (>5 units). Women who received Massive transfusion of blood or red cells (>5 units) and
hysterectomy are counted as near miss according to WHO criteria.
a Women suffered at least one maternal morbidity
b There was only one postpartum woman suffered near miss event included in this category.
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287 (18.4%) and pre-eclampsia/eclampsia 65 (4.2%). Two women
had a ruptured uterus, one after vaginal birth and the second after CS
and neither had had a previous cesarean section. Twenty-four
women gave birth vaginally and received treatments, but surpris-
ingly no complication was mentioned in their records, (i.e. received
blood with no mention of hemorrhage). Massive interventions to
treat morbidities such as large transfusion of blood or red cells (more
than ﬁve units), hysterectomy, and ICU admission were more
frequent in women after cesarean section as shown in Table 3.
3.3. Patterns of medical management for selected morbidities
3.3.1. Hemorrhage
Oxytocin was administered after birth to prevent PPH in 88% of
women who gave birth vaginally and 98% of women who had CS. InTable 4
Selected perinatal outcomes of women.






Total women 419 (26.9) 1139 (73.1)
Total newborns delivered 130 1079
Live birth 124 (95.4) 1071 (99.3)
Stillbirth 6 (4.6) 8 (0.74)
Early neonatal deatha 8 (6.5) 13 (1.2)
Cesarean section 61 (46.9) 232 (21.5)
Birth weight
<2500 g 27 (20.8) 79 (7.3)
2500–4000 g 96 (73.9) 926 (85.8)
>4000 g 7 (5.4) 74 (6.9)
Selected intervention for newbornb
Admission to NICU 22 (17.7) 73 (6.8)
Intubation 7 (5.7) 14 (1.3)
Cardiopulmonary resuscitation 2 (1.6) 4 (0.4)
Corticosteroids for fetal lung maturity 31 (25) 21 (1.95)
a Early neonatal death represents only total newborns died until day 7 after birth.
b Neonatal interventions were calculated from total live births.addition, there were 179 (24.6%) women who received other
uterotonic medications (Ergometrine and/Misoprostol) routinely
after vaginal birth and 282 (92%) women after cesarean
section. All (100%) women who had PPH after vaginal birth
received routine oxytocin after birth, but only seven out of nine
women who had PPH after CS received routine oxytocin after
delivery to prevent PPH. Of all women who had PPH (n = 31), ﬁve
women (16.1%) received more than ﬁve units of blood to treat
PPH, three underwent a hysterectomy, and four were admitted
to the ICU.
There were 37 (3.6%) women who suffered from other obstetric
hemorrhage during labour/delivery. The coverage of oxytocin to
prevent PPH was 82.4% and 100% after vaginal delivery and
cesarean section, respectively. Of all women who suffered
hemorrhage during childbirth (n = 68) (Table 3), 11 women
experienced organ dysfunction (near-miss). Moreover, a total of
99 women were treated for hemorrhage during/after delivery/
abortion by medications or other methods such as balloon or
condom temponade, removal of retained placenta, blood transfu-
sion or laparotomy. However, it was not documented that these
women experienced hemorrhage.
3.3.2. Induction of labour
Out of 1209 women who gave birth, 131 (10.8%) women had
labour induced. Among these 48 (36.6%) women were primipa-
rae, six women had a previous cesarean section and 31 (23.7%)
gave birth by CS. Of all women had labour induced, 23 (17.6%)
had some kind of morbidity and two women were identiﬁed as
near-miss cases. The most frequent morbidities found in this
group of women were, hemorrhage (10 (8%) women), removal of
retained products (2 women), blood transfusion (5 women),
laparotomy (2 women), and one woman had a hysterectomy and
was admitted to the ICU. It is also worth noting that 55 (42%)
women had labour induced before 40 weeks of gestation, 11
women had preeclampsia, 5 newborns were stillbirths, 12 (9.2%)
newborns suffered a complication and six newborns were
admitted to the NICU.
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Among all women, 62 (4%) women had preeclampsia and three
women were diagnosed with eclampsia. Among these 65 women,
46 (71%) gave birth, 19 (29%) pregnant women were discharged.
Among all women who had preeclampsia/eclampsia, only 13 (20%)
women received magnesium sulfate, three (5%) women were
admitted to the ICU, and 27 (41.5%) gave birth by cesarean section.
3.3.4. Preterm labour
Of all women, 126 (8.1%) were admitted for preterm labour
(gestational age 25–36 weeks). Among the women with suspected
preterm labour who gave birth, 77 (61%) delivered vaginally, 48
(38%) delivered by CS, and one had an evacuation of pregnancy
using medical methods at 27 weeks gestation. Of the 126 women,
only ﬁve (4%) women gave birth within the ﬁrst 3 h of arrival. Four
(3%) of these women ended up as near-miss cases.
The most frequent documented modes of management for
these women were bed rest 28 (22.2%) and hydration 23 (18.3%).
Betamimetics were administered only for two women to suppress
labour. Eleven (8.7%) of these women were classiﬁed as
preeclampsia/eclampsia cases, ﬁve (4%) women had chronic
hypertension, eight (6.3%) suffered hemorrhage during or after
delivery, three women were admitted to the ICU, and one had a
hysterectomy. Eight (6.4%) newborns were delivered stillborn, and
14 (11.2%) newborns died before discharge from the hospital.
There were 47 (40.2%) newborn admitted to NICU, six (5.1%) died
after NICU admission and corticosteroids were only administered
to 52 (41.3%) women.
3.3.5. Cesarean section
Among the 1209 women who gave birth 293 (24.2%) had a CS.
The mean (SD) age of these women was 29.2 (6.1) years, and the
mean (SD) gestational age was 37.9 (2.6) weeks. Of the 293 women,
half of them had no previous CS (64 primiparae and 82 multiparae);
72 (24.6%) women had one previous CS, 63 (21.5%) women had 2–3
previous CS, and 12 (4.1%) women had more than three CS (ranged
from 4 to 6 CS). In addition, of all women who gave birth by CS
(n = 293), 31 (10.6%) women were induced for labour, about half of
the women 141 (48.1%) were admitted with no labour and 263
(90%) women received prophylactic antibiotics. The women who
delivered by CS suffered various morbidities and eight (2.7%) were
classiﬁed as near-miss according to WHO criteria. Of the most
frequent morbidities, 27 (9.2%) women had preeclampsia/eclamp-
sia, 26 (8.9%) women had hemorrhage during or after delivery, 18
(6.1%) women received blood products, four women had laparoto-
my and three had hysterectomies. On the other hand, of all vaginal
births (n = 927), 63 (7%) women successfully delivered vaginally
after a previous CS. Of all newborns delivered by CS, there were ﬁve
stillbirths (3 fresh and 2 macerated), 44 (15%) newborns were
admitted to the NICU, and nine newborns died before discharge
from the hospital (by day 7) (Table 4).
4. Discussion
This is the ﬁrst report on types of maternal morbidities, the
patterns of hospital-based management of these conditions and
selected newborn outcomes using a comprehensive framework
including near miss events. The main ﬁndings of this study indicate
that more than a quarter of Palestinian women experienced
various morbidities (severe/non-severe) during pregnancy and
childbirth, mainly related to abortion and childbirth. Although the
incidence of each speciﬁc type of maternal morbidity seems low,
the burden of total morbidities is high.
The morbidity rate of life-threatening near-miss conditions was
1% using the WHO criteria,20 about half of the rate found in a
retrospective study of near miss cases in four Palestinianhospitals21 using different criteria. Out of more than a quarter
of Palestinian women experiencing at least one morbidity, the
largest proportion were women who had abortions while the most
common complication was abortion-related hemorrhage. In
Palestine, despite the awareness, availability and accessibility of
family planning services, the reported unmet need in 2010 was
15.6%22 which is higher than that of Jordan (14%), Egypt (11.5%),
and Israel (9.1%).23 This suggests that there is a proportion of
‘‘unwanted’’/‘‘unintended’’ pregnancies. In 2006, about 40% of a
national sample of Palestinian pregnant women reported their
pregnancy as ‘‘unintended’’24 which could be attributed to the
limited access to or inadequate family planning services.
In our sample, 12.6% of women had a miscarriage/abortion,
falling within the estimated range by the WHO of abortions due to
unwanted/unintended pregnancies. Globally, in 2011, 5–20% of
unwanted pregnancies resulted in miscarriage, stillbirth or
abortion.25 In Palestine, abortion is illegal by law and is not
accepted by the Islamic society for religious reasons except to save
the mother’s life, which increases the burden of maternal
morbidity related to abortion on the health system.25 Moreover,
in cases of unwanted pregnancies, women seek abortions either in
private clinics or use traditional methods at home which may
result in abortion-related hemorrhage and ultimately women with
such cases show up at the hospital complaining of hemorrhage.26
The most common forms of management were medical methods
followed by curettage, which are unsafe practices as complications
are 2–3 times higher than vacuum aspiration method and more
costly.27 Providers must be trained on evidence-based practices
and safe abortion care.
In this study, complications during pregnancy included
antepartum hemorrhage, preeclampsia/eclampsia, infection and
indirect cases which is consistent with reports from other
studies.14,28 Hemorrhage during pregnancy mainly due to placenta
conditions such as praevia, abruption or accreta, raises questions
related to increasing rates of cesarean deliveries in Palestine. High
risk pregnancies place heavy burdens on the health system.
Although coverage of antenatal care in Palestine is high, little is
known about the quality of antenatal care. Additionally, that calls
for the availability and accessibility to an effective continuous
and essential quality obstetric care from early pregnancy onward
and timely interventions to manage complications in Palestinian
hospitals.
The two most common causes of maternal morbidity in this
hospital were hemorrhage (17.8%) and preeclampsia/eclampsia
(4.2%) similar to ﬁndings from another Palestinian study21 and
elsewhere.14 The incidence of preeclampsia/eclampsia in our study
was double the incidence reported from Palestine in the WHO
multi-country survey (4.2% vs 2.4%).29 Consequently, strategies
must be developed to allow early identiﬁcation and effective
antenatal treatment for women suffering from preeclampsia/
eclampsia, to provide proper management during childbirth and
prevent life-threatening complications.
Magnesium sulfate is the medicine of choice to reduce risks of
severe pre-eclampsia and eclampsia.30 In this study, it was
administered to only 13 (20%) of women with pre-eclampsia/
eclampsia, contrary to reports in the WHO survey (100%)29 and less
than reports from Iraq.14 Previous research in this hospital31
indicates that barriers to usage of magnesium sulfate for pre-
eclampsia included lack of availability, insufﬁcient knowledge, and
weak bedside nursing due to high workload and insufﬁcient staff.32
Hemorrhagic disorders were the most common complications
among women (18.4%), which is lower than those reported in
similar facility-based studies.33 PPH is one of the most frequent
causes of maternal death in Palestine.34 In our study, the incidence
of PPH falls within the expected rate by the WHO (2%),35 which is
much lower than the prevalence reported from Africa (6%),36 and
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near-miss study (2% vs 18.4%). However, since there were women
who were treated for hemorrhage, but were not clearly docu-
mented in the records, we believe that the incidence of PPH in our
study could be underestimated due to inadequate documentation.
Inadequate documentation was also acknowledged in the Pales-
tinian retrospective study.21 Despite this fact, the coverage of
uterotonics for prevention of PPH by oxytocin was high, similar to
ﬁndings from Iraq,14 and higher after vaginal deliveries than
cesarean sections. This could be because midwives who assist most
vaginal deliveries are keen to follow the standards to prevent PPH
i.e. active management of third stage of labour. However, CS occur
in the main operating theatre, where it is likely that nurses are
busy with other tasks and are unable to monitor and give oxytocin
IM for each woman after the operation in a timely manner. On the
other hand, when PPH occurred after CS, coverage rates for
uterotonics was 100%, including misoprostol. Some women
received more than one uterotonic including ergometrine and
misoprostol for prevention of PPH which is contrary to the WHO
recommendations.37
Our ﬁndings revealed that some women suffered morbidities
that were not explicitly documented in their medical records. This
reﬂects the insufﬁcient documentation and information system. A
woman who received two or three units of blood (a special sticker
ﬁxed inside the ﬁle from the given unit of blood), or who had a
laparotomy (from the operative sheet) most likely suffered from
hemorrhage, but it was not explicitly documented in physicians’ or
nurses’ progress notes. In addition, manual removal of placenta is
signiﬁcantly associated with morbidities such as endometritis.38
About one quarter of women delivered by CS, and half of them
were primary CS (CS for the ﬁrst time), exceeding the average
national rate of CS deliveries (20.3%).4 In Palestine, where the
fertility rate is 4.1,4 women who have had primary CS will most
likely continue to have operative deliveries in the future, with the
subsequent risks in each additional pregnancy and delivery. CS
rates have almost doubled in the last two decades in Palestine.9 In
2011, the CS rate has reached 32% in a governmental hospital39 and
maternal mortality in Palestine was signiﬁcantly associated with
CS.40 Reasons for this escalation in CS rates include a decrease in
vaginal births after cesarean (VBAC), increased number of high-risk
expectant mothers due to primary CS, and the changes in
obstetrical environment and provider practices.41,42 Unlike some
countries where maternal request has been given as a justiﬁcation
for CS, Palestinian women prefer to give birth vaginally.42
However, women may not ask about the exact indications,
available alternative management or potential risks once a CS is
decided for them. Additionally, we found that preeclampsia could
have been an indication for 9% of women who were delivered by
CS, which is consistent with literature from other countries.43 On
the other hand, the evidence that supports CS as a mode of delivery
of choice for women with preeclampsia is weak.44
Our study revealed that women who gave birth with CS
experienced various morbidities such as hysterectomies, blood
transfusion and near-miss three times more than women who gave
birth vaginally. Studies have shown that cesarean deliveries
increase the risk of hysterectomies, blood transfusions, adhesions,
placenta praevia, abruption, accreta, surgical injury45 and post-
partum complications such as endometritis and death.46 The
escalation of CS rates in many countries has been considered a
serious public health dilemma, increasing risks of maternal and
newborn morbidities, disabilities and death and causing a heavy
ﬁnancial burden on the health system.47 This emphasizes the need
for promoting normal childbirth and eliminating unnecessary
interventions for low risk women, particularly in this context
where parity is high. Strategies for maternal health should focus on
supporting the role of midwives in assisting women duringchildbirth as well as strengthening their capabilities and self-
conﬁdence in leading a non-interventionist approach in hospitals,
thus enabling obstetricians to focus on the high-risk cases and
complications.
Inappropriate use of induction of labour has been associated
with maternal and neonatal morbidities, including PPH.48 In our
study, induction was more frequent before term. Of all women
induced before term, 11 women had preeclampsia, which could be
a reason for induction. Women who underwent induction
experienced a variety of complications such as, PPH, hysterectomy,
laparotomy, blood transfusion, retained placental products and
admission to the ICU and NICU, and could represent a heavy
ﬁnancial burden on scarce resources. The prevalence of induction
of labour in our study was lower than rates reported from Asia, but
higher than rates reported from Africa.48 However, the prevalence
of women who successfully gave birth vaginally after induction of
labour was lower than reports from both Africa and Asia48 (76% of
women had labour induced in this study gave birth vaginally vs
83% in Africa and 81% in Asia).
This study has several limitations. The data collection was from
one hospital. However, this hospital is one of many operating
under the same health system and the ﬁndings are likely to be
similar to other governmental hospitals. Another limitation was
that we could not identify more details on abortions/miscarriages.
The study could not identify all morbidities related to abortion as
many women prefer to seek care for abortion/miscarriage in
private clinics/hospitals. This leads us to believe there could be
underreporting or misclassiﬁcations of abortion cases. Further-
more, the data lacks demographic information as hospital does not
collect this data routinely (i.e. education, employment, place of
residence), information about indications of augmentation and
induction of labour and cesarean sections to judge the rationale for
the use of these invasive procedures and estimate rates of obstructed
labour and determinants. The limited number of women with
complications during the postpartum period makes one wonder
whether women with perineal problems and other complications
were lost to follow-up. Finally, we tried to be as speciﬁc as possible
with the records that were available; we recognize that in some
cases the data was not comprehensive, but it contributes to the
dearth of information on maternal morbidities in this context.
5. Conclusion
The burden of maternal morbidity for Palestinian women is
relatively high which suggests a problem of substandard quality of
care. Our ﬁndings should prompt adoption of best practices during
the continuum of care for maternal and newborn healthcare. There
are many challenges to the organization and implementation of
quality care hindered by political instability and restrictions on
movement in this occupied country. Despite the courage and
commitment of Palestinian health providers, much can still be
done at the local policy and health service level to improve the
outcomes of women and newborns. Morbidity related to cesarean
sections is a serious public health problem that requires national
strategies to promote a strong rationale for use of such procedure.
It is worth investing in improving the care of midwives and
obstetricians to assist women during birth with appropriate
evidence-based practices, avoiding unnecessary medicalization
and treating complications effectively without delays. Abortion
related morbidity can be prevented by reducing unwanted
pregnancies, improving the quality of family planning services
and training/updating practices of providers related to abortion
care particularly in vacuum aspiration procedures and medical
procedures given the frequent complications related to abortion.
Further studies are needed to address health system barriers to
accurately document and monitor maternal morbidities including
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delivery and induction of labour, as well as enabling midwives and
physicians to assist normal childbirth conﬁdently while avoiding
interventions as much as possible. Finally, rigorous and routine
documentation of the details of childbirth events is necessary to
identify maternal morbidities, disabilities, and suffering in order
to inform policy makers and develop strategies to allocate
resources to assist in reducing maternal morbidities and death.
This analysis provided only a glimpse into the burden of maternal
morbidity. Further studies are needed to estimate the incidence,
trends, and management of maternal morbidity at the national
level and to explore women’s perspectives and views about
unintended pregnancies, trends and management of abortion-
related complications.
Authors’ contribution
All authors contributed to the conception and design of the
whole research. SH and LW supervised the ﬁeld work. SH trained
the ﬁeld workers on data extraction, closely monitored data
collection and entry, conceptualized this paper, analyzed
the data, and drafted and revised the manuscript. LW and JD
reviewed and critically commented on the manuscript. JD
supervised the multi-country study. All authors read and
approved the ﬁnal version.
Conﬂict of interest
The authors declare that they have no competing interest.
Acknowledgements
The authors wish to thank the Palestinian Ministry of Health,
the administration of Ramallah hospital and Head of the Maternity
ward, Dr Samir Abu Eideh for facilitating the participation of
Ramallah hospital in this study. We also acknowledge all midwives
and physicians at Ramallah hospital for facilitating our work
during the data collection in the hospital. We are grateful to
Professor Martin O’Flaherty from University of Liverpool for
reviewing and commenting on the ﬁrst semi-ﬁnal version of this
paper. Special thanks go to the Reproductive Health Working
Group (Arab country and Turkey) for funding the time of SH to draft
this paper through their seed funding scheme through a grant from
the International Development Research Centre, Ottawa, Canada.
This study was funded by a grant from the Implementation
Research Platform managed by the World Health Organization
(Implementation Research Protocol ID A65770) to the Faculty of
Health Sciences, American University of Beirut for a four-country
study on maternal near-miss in public hospitals in Egypt, Lebanon,
Palestine and Syria.
References
1. DeJong J, Bahubaishi N, Attal B. Effects of reproductive morbidity on women’s
lives and costs of accessing treatment in Yemen. Reprod Health Matters
2012;20(40):129–38.
2. Hassan SJ, Sundby J, Husseini A, Bjertness E. Translating evidence into practice
in childbirth: a case from the Occupied Palestinian Territory. Women Birth
2013;26:e82–9.
3. Prata N, Passano P, Sreenivas A, Gerdts CE. Maternal mortality in developing
countries: challenges in scaling-up priority interventions. Womens Health (Lond
Engl) 2010;6(2):311–27.
4. Palestinian Central Bureau of Statistics. Palestinian multiple indicator cluster
survey 2014, Key findings report. Ramallah, Palestine: Palestinian Central Bureau
of Statistics; 2014.
5. The Maternal Morbidity Network. The base of the iceberg: prevalence and
perceptions of maternal morbidity in four developing countries. Research Trian-
gle Park, NC 27709, USA: Family Health International; 1997.
6. Vanderkruik RC, Tunc¸alp O¨., Chou D, Say L. Framing maternal morbidity: WHO
scoping exercise. BMC Pregnancy Childbirth 2013;13(213):213.7. Say L, Pattinson RC, Gulmezoglu AM. WHO systematic review of maternal
morbidity and mortality: the prevalence of sever acute maternal morbidity
(near miss). BMC Reprod Health 2004;1(1):3.
8. Choices Challenges in Changing Childbirth Research Network. Routines in
facility-based maternity care: evidence from the Arab World. BJOG
2005;112(September):1270–6.
9. Abdul-Rahim HF, Abu-Rmeileh NM, Wick L. Cesarean section deliveries in the
occupied Palestinian territory (oPt): an analysis of the 2006 Palestinian Family
Health Survey. Health Policy 2009;93(2/3):151–6.
10. Khawaja M, Choueiry N, Jurdi R. Hospital-based caesarean section in the Arab
region: an overview. East Mediterr Health J 2009;15(2):458–69.
11. Fathalla MF. Reducing the burden of maternal and child morbidity and mortali-
ty in the Eastern Mediterranean Region? Yes, we can. EMHJ 2014;20(1):5–9.
12. Assarag B, Dubourg D, Maarouﬁ A, Dujardin B, De Brouwere V. Maternal
postpartum morbidity in Marrakech: what women feel what doctors diagnose?
BMC Pregnancy Childbirth 2013;13(225):225.
13. Bener A, Al-Nufal M, Vachhani PJ, Ali AI, Samson N, Saleh NM. Maternal
complications and neonatal outcome in Arab women of a fast developing
country. J Fam Commun Med 2013;20(1):27–34.
14. Jabir M, Abdul-Salam I, Suheil DM, Al-Hilli W, Abul-Hassan S, Al-Zuheiri A, et al.
Maternal near miss and quality of maternal health care in Baghdad, Iraq. BMC
Pregnancy Childbirth 2013;13:11.
15. Koblinsky M, Chowdhury ME, Moran A, Ronsmans C. Maternal morbidity and
disability and their consequences: neglected agenda in maternal health. J
Health Popul Nutr 2012;30(2):124–30.
16. Rahim HF, Wick L, Halileh S, Hassan-Bitar S, Chekir H, Watt G, et al. Maternal and
child health in the occupied Palestinian territory. Lancet 2009;373(9667):967–77.
17. UNDP/UNFPA/WHO/World Bank. WHO multicountry survey on maternal and
newborn health project A65661. Geneva, Switzerland: World Health Organiza-
tion; 2009.
18. United States Agency for International Development. User guide: CSPRO data
entry and analysis software for implementers of USAID poverty assessment tools.
USA: United States Agency for International Development; 2010, July.
19. Fottrell E, Hogberg U, Ronsmans C, Osrin D, Azad K, Nair N, et al. A probabilistic
method to estimate the burden of maternal morbidity in resource-poor set-
tings: preliminary development and evaluation. Emerg Themes Epidemiol
2014;11(1):3.
20. Souza JP, Gulmezoglu AM, Carroli G, Lumbiganon P, Qureshi Z, Group WR. The
world health organization multicountry survey on maternal and newborn
health: study protocol. BMC Health Serv Res 2011;11:286.
21. UNFPA Juzoor for Health Social Development. Maternal near miss in four
governmental hospitals in the West Bank in 2010. Ramallah, Palestine: UNFPA,
Juzoor for Health & Social Development; 2012.
22. Palestinian Central Bureau of Statistics. Monitoring the situation of children and
women: Family Health Survey 2010. Ramallah, Palestine: PCBS, UNFPA, UNICIF;
2013.
23. United Nations. DoEaSA Population Division. World Contraceptive Use 2012.
United Nations; 2012.
24. Palestinian Central Bureau of Statistics (PCBS). Palestinian Family Health Survey,
2006: Final report Ramallah. PCBS; 2007.
25. World Health Organization (WHO). Unsafe abortion: global and regional esti-
mates of the incidence of unsafe abortion and associated mortality in 2008. 6th
ed. Geneva: WHO; 2011.
26. AlRifai A. Assessment of Safe and Unsafe Abortion among Palestinian Women in
Hebron Governorate in Southern West Bank, Palestine. Jerusalem Family Plan-
ning and Protection Association; 2015.
27. World Health Organization (WHO). Safe abortion: technical and policy guidance
and policy guidance for health systems. second ed. Geneva: WHO; 2012.
28. Danel I, Berg C, Johnson CH, Atrash H. Magnitude of maternal morbidity during
labor and delivery: United States, 1993–1997. Am J Public Health 2003;93(4):
631–4.
29. Abalos E, Cuesta C, Carroli G, Qureshi Z, Widmer M, Vogel JP, et al. Pre-
eclampsia, eclampsia and adverse maternal and perinatal outcomes: a second-
ary analysis of the World Health Organization Multicountry Survey on Maternal
and Newborn Health. BJOG 2014;121(Suppl. 1):14–24.
30. Duley L, Gu¨lmezoglu AM, Henderson-Smart DJ. Magnesium sulphate and other
anticonvulsants for women with pre-eclampsia. The Cochrane Collaboration.
JohnWiley & Sons, Ltd.; 2007: 74.
31. Hassan-Bitar S, Wick L. Evoking the guardian angel: childbirth care in a
Palestinian hospital. Reprod Health Matters 2007;15(30):103–13.
32. Bigdeli M, Zafar S, Assad H, Ghaffar A. Health system barriers to access and use
of magnesium sulfate for women with severe pre-eclampsia and eclampsia in
Pakistan: evidence for policy and practice. PLoS ONE 2013;8(3):e59158.
33. Prual A, Bouvier-Colle MH, De Beris L, Breart G. Sever maternal morbidity from
direct obstetric causes in West Africa: incidence and case fatality rates. Bull
World Health Org 2000;78(5):593–602.
34. Ministry of Health PHIC. Health status in Palestine 2013. Ramallah: Ministry of
Health; 2014, June.
35. World Health Organization. WHO recommendations for the prevention and
treatment of postpartum haemorrhage. Italy: World Health Organization; 2012.
36. Fawole B, Awolude OA, Adeniji AO, Onafowokan O. WHO recommendations for
the prevention of postpartum haemorrhage: RHL guideline The WHO Reproduc-
tive Health Library. World Health Organization; 2010, May.
37. Tang J, Kapp N, Dragoman M, de Souza JP. WHO recommendations for miso-
prostol use for obstetric and gynecologic indications. Int J Gynaecol Obstet
2013;121(2):186–9.
S.J. Hassan et al. / Women and Birth 28 (2015) e148–e156e15638. Atkinson MW, Owen JWA, Hauth JC. The effect of manual removal of the
placenta on post-cesarean endometritis. Obstet Gynecol 1996;87(1):99–102.
39. Ministry of Health PHIC. Health status in Palestine 2011. Ramallah: Ministry of
Health; 2012, May.
40. UNFPA, Palestinian Ministry of Health. Report on maternal mortality in Pales-
tine. Ramallah: Palestinian Ministry of Health; 2011.
41. Mikki N, Abu-Rmeileh NM, Wick L, Abu-Asab N, Hassan-Bitar S. Caesarean
delivery rates, determinants and indications in Makassed Hospital, Jerusalem
1993 and 2002. East Mediterr Health J 2009;15(4):868–79.
42. Menacker F, Hamilton BE. Recent trends in cesarean delivery in the United
States. NCHS DataBrief 2010:1–8.
43. Barber EL, Lundsberg LS, Belanger K, Pettker CM, Funai EF, Illuzzi JL. Indications
contributing to the increasing cesarean delivery rate. Obstet Gynecol 2011;118(1):
29–38.
44. The Royal College of Obstetricians Gynaecologists. The management of sever pre-
eclampsia/eclampsia. Setting standards to improve women’s health. UK: The Royal
College of Obstetricians and Gynaecologists; 2006, March. Reviewed 2010, p. 11.45. Marshall NE, Fu R, Guise JM. Impact of multiple cesarean deliveries on
maternal morbidity: a systematic review. Am J Obstet Gynecol 2011;205(3).
262.e1–e8.
46. Loverro G, Greco P, Vimercati A, Nicolardi V, Varcaccio-Garofalo G, Selvaggi L.
Maternal complications associated with cesarean section. J Perinat Med
2001;29(4):322–6.
47. Gibbons L, Beliza´n J, Lauer J, Betra´n A, Merialdi M, Althabe F. The global numbers
and costs of additionally needed and unnecessary caesarean sections performed
per year: overuse as a barrier to universal coverage background paper no
30. World Health Report. 2010:32.
48. Vogel JP, Souza JP, Gulmezoglu AM. Patterns and outcomes of induction of
labour in Africa and Asia: a secondary analysis of the WHO Global Survey on
Maternal and Neonatal Health. PLoS ONE 2013;8(6):e65612.
49. World Health Organization. The WHO Application of ICD-10 to deaths during
pregnancy childbirth and the puerperium: ICD-MM. France: World Health Orga-
nization; 2012.
